Literature DB >> 30528424

Molecular characterization of influenza viruses from women and infants in Sarlahi, Nepal.

Jane Kuypers1, Helen Y Chu2, Charlotte A Gaydos3, Joanne Katz4, Subarna K Khatry5, Steven C LeClerq6, James M Tielsch7, Mark C Steinhoff8, Janet A Englund9.   

Abstract

We used RT-PCR-electrospray ionization-mass spectrometry to identify subtypes and strains of influenza viruses detected during a maternal influenza immunization study in Nepal from May 2011 to April 2014. Hemagglutinin (HA) gene amino acid (aa) sequences of inferred reference strains were compared to those of the vaccines to determine impact of aa relatedness on vaccine efficacy (VE) and disease severity. Three influenza subtypes and many strains were identified. A(H3N2) strains with less than 13 aa differences in HA compared to vaccine strains (matched) showed higher VE than strains with 13 or more differences (mismatched). Yamagata lineage B strains, which were mismatched to the Victoria strain in the vaccine, demonstrated lower VE compared to Victoria strains. Differences in VE were not statistically significant. All A(H1N1pdm) matched the vaccine strain, with 10 or fewer aa differences. Except for women infected with vaccine-matched strains of influenza A, clinical signs and symptoms did not differ between vaccinated and unvaccinated participants.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  Electrospray ionization-mass spectrometry; Influenza immunization; Influenza subtypes

Mesh:

Substances:

Year:  2018        PMID: 30528424      PMCID: PMC7566802          DOI: 10.1016/j.diagmicrobio.2018.11.004

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  25 in total

1.  Application of a 16S rRNA PCR-high-resolution melt analysis assay for rapid detection of Salmonella Bacteremia.

Authors:  Kevin Jeng; Samuel Yang; Helen Won; Charlotte A Gaydos; Yu-Hsiang Hsieh; Alex Kecojevic; Karen C Carroll; Justin Hardick; Richard E Rothman
Journal:  J Clin Microbiol       Date:  2012-01-11       Impact factor: 5.948

2.  Demise of Polymerase Chain Reaction/Electrospray Ionization-Mass Spectrometry as an Infectious Diseases Diagnostic Tool.

Authors:  Volkan Özenci; Robin Patel; Måns Ullberg; Kristoffer Strålin
Journal:  Clin Infect Dis       Date:  2018-01-18       Impact factor: 9.079

3.  Year-round influenza immunisation during pregnancy in Nepal: a phase 4, randomised, placebo-controlled trial.

Authors:  Mark C Steinhoff; Joanne Katz; Janet A Englund; Subarna K Khatry; Laxman Shrestha; Jane Kuypers; Laveta Stewart; Luke C Mullany; Helen Y Chu; Steven C LeClerq; Naoko Kozuki; Monica McNeal; Adriana M Reedy; James M Tielsch
Journal:  Lancet Infect Dis       Date:  2017-05-15       Impact factor: 25.071

4.  Monitoring seasonal influenza A evolution: rapid 2009 pandemic H1N1 surveillance with an reverse transcription-polymerase chain reaction/electro-spray ionization mass spectrometry assay.

Authors:  Kevin Jeng; Christian Massire; Teresa R Zembower; Varough M Deyde; Larisa V Gubareva; Yu-Hsiang Hsieh; Richard E Rothman; Rangarajan Sampath; Sudhir Penugonda; David Metzgar; Lawrence B Blyn; Justin Hardick; Charlotte A Gaydos
Journal:  J Clin Virol       Date:  2012-06-04       Impact factor: 3.168

5.  Comparison of a multiplex real-time PCR assay with a multiplex Luminex assay for influenza virus detection.

Authors:  Sandra B Munro; Jane Kuypers; Keith R Jerome
Journal:  J Clin Microbiol       Date:  2013-01-23       Impact factor: 5.948

6.  Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution.

Authors:  Björn F Koel; David F Burke; Theo M Bestebroer; Stefan van der Vliet; Gerben C M Zondag; Gaby Vervaet; Eugene Skepner; Nicola S Lewis; Monique I J Spronken; Colin A Russell; Mikhail Y Eropkin; Aeron C Hurt; Ian G Barr; Jan C de Jong; Guus F Rimmelzwaan; Albert D M E Osterhaus; Ron A M Fouchier; Derek J Smith
Journal:  Science       Date:  2013-11-22       Impact factor: 47.728

7.  Mapping the antigenic and genetic evolution of influenza virus.

Authors:  Derek J Smith; Alan S Lapedes; Jan C de Jong; Theo M Bestebroer; Guus F Rimmelzwaan; Albert D M E Osterhaus; Ron A M Fouchier
Journal:  Science       Date:  2004-06-24       Impact factor: 47.728

8.  Strengthening the influenza vaccine virus selection and development process: Report of the 3rd WHO Informal Consultation for Improving Influenza Vaccine Virus Selection held at WHO headquarters, Geneva, Switzerland, 1-3 April 2014.

Authors:  William K Ampofo; Eduardo Azziz-Baumgartner; Uzma Bashir; Nancy J Cox; Rodrigo Fasce; Maria Giovanni; Gary Grohmann; Sue Huang; Jackie Katz; Alla Mironenko; Talat Mokhtari-Azad; Pretty Multihartina Sasono; Mahmudur Rahman; Pathom Sawanpanyalert; Marilda Siqueira; Anthony L Waddell; Lillian Waiboci; John Wood; Wenqing Zhang; Thedi Ziegler
Journal:  Vaccine       Date:  2015-07-03       Impact factor: 3.641

9.  Comparison of clinical features and outcomes of medically attended influenza A and influenza B in a defined population over four seasons: 2004-2005 through 2007-2008.

Authors:  Stephanie A Irving; Darshan C Patel; Burney A Kieke; James G Donahue; Mary F Vandermause; David K Shay; Edward A Belongia
Journal:  Influenza Other Respir Viruses       Date:  2011-05-25       Impact factor: 4.380

10.  Genetic divergence of Influenza A(H3N2) amino acid substitutions mark the beginning of the 2016-2017 winter season in Israel.

Authors:  Aharona Glatman-Freedman; Yaron Drori; Sharon Alexandra Beni; Nehemya Friedman; Rakefet Pando; Hanna Sefty; Ilana Tal; John McCauley; Galia Rahav; Nathan Keller; Tamy Shohat; Ella Mendelson; Musa Hindiyeh; Michal Mandelboim
Journal:  J Clin Virol       Date:  2017-06-04       Impact factor: 3.168

View more
  1 in total

1.  Assessment of indirect protection from maternal influenza immunization among non-vaccinated household family members in a randomized controlled trial in Sarlahi, Nepal.

Authors:  Kira L Newman; Laveta M Stewart; Emily M Scott; James M Tielsch; Janet A Englund; Subarna K Khatry; Luke C Mullany; Steven C LeClerq; Laxman Shrestha; Jane M Kuypers; Helen Y Chu; Joanne Katz
Journal:  Vaccine       Date:  2020-08-17       Impact factor: 3.641

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.